While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

Bila Solar is manufacturing ultra-lightweight solar modules and newly launched 550 W dual-glass conventional panels in its ...

Behind-the-scenes video captures this milestone for American solar - creating local jobs and reinforcing why federal support ...

In today's Pharmalittle roundup, we're reading about a Sarepta setback with its Duchenne drug, the FDA workload causing a ...

Bila Solar has begun producing its new line of silicon solar panels at its Indianapolis factory, the company announced. “This ...

With more than $270 billion in commitments to date, a new wave of pharmaceutical manufacturing is slated to hit the US. At least, that’s what the industry is trying to project.